Skip to main content

Revolution Medicines, Inc.

RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001628171

In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.

Other share classesRVMDW

13F holders, Q3 2023

Institutional positions in Revolution Medicines, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
168
+29 vs. Q2 2023
Shares held
112.4M
+450.9K (+0.4%) vs. Q2 2023
Total value
$3.11B
+$117.1M (+3.9%) vs. Q2 2023
New holders
42
60 more added
Sold out
13
39 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 168 institutions
Q1 2021: 128 institutionsQ2 2021: 130 institutionsQ3 2021: 114 institutionsQ4 2021: 117 institutionsQ1 2022: 126 institutionsQ2 2022: 135 institutionsQ3 2022: 142 institutionsQ4 2022: 135 institutionsQ1 2023: 152 institutionsQ2 2023: 139 institutionsQ3 2023: 168 institutionsQ4 2023: 184 institutionsQ1 2024: 210 institutionsQ2 2024: 223 institutionsQ3 2024: 255 institutionsQ4 2024: 281 institutionsQ1 2025: 284 institutionsQ2 2025: 308 institutionsQ3 2025: 323 institutionsQ4 2025: 387 institutionsQ1 2026: 514 institutionsQ2 2026: 693 institutions
Value heldQ3 2023: $3.11B
Q1 2021: $3.05BQ2 2021: $2.23BQ3 2021: $1.99BQ4 2021: $1.85BQ1 2022: $1.89BQ2 2022: $1.49BQ3 2022: $1.74BQ4 2022: $2.10BQ1 2023: $2.34BQ2 2023: $2.99BQ3 2023: $3.11BQ4 2023: $4.59BQ1 2024: $5.18BQ2 2024: $6.54BQ3 2024: $7.74BQ4 2024: $8.45BQ1 2025: $6.83BQ2 2025: $7.02BQ3 2025: $8.96BQ4 2025: $15.9BQ1 2026: $19.1BQ2 2026: $40.1B
Institutions holding RVMD and their total value by quarter
QuarterHoldersValue
Q2 2026693$40.1B
Q1 2026514$19.1B
Q4 2025387$15.9B
Q3 2025323$8.96B
Q2 2025308$7.02B
Q1 2025284$6.83B
Q4 2024281$8.45B
Q3 2024255$7.74B
Q2 2024223$6.54B
Q1 2024210$5.18B
Q4 2023184$4.59B
Q3 2023168$3.11B
Q2 2023139$2.99B
Q1 2023152$2.34B
Q4 2022135$2.10B
Q3 2022142$1.74B
Q2 2022135$1.49B
Q1 2022126$1.89B
Q4 2021117$1.85B
Q3 2021114$1.99B
Q2 2021130$2.23B
Q1 2021128$3.05B

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q2 2023.

Institutions holding RVMD in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG97,159$2.69M0.00%−39,295−28.8%Reduced
Citigroup Inc97,234$2.69M0.00%−25,290−20.6%Reduced
UBS Asset Management Americas Inc104,238$2.89M0.00%+13,913+15.4%Added
Squarepoint Ops LLC117,302$3.25M0.02%+90,623+339.7%Added
Sectoral Asset Management Inc142,650$3.95M0.77%+142,650New
Rhumbline Advisers145,572$4.03M0.00%+6,894+5.0%Added
ExodusPoint Capital Management, LP152,290$4.21M0.05%+152,290New
Manufacturers Life Insurance Company, The155,536$4.31M0.00%+18,204+13.3%Added
Swiss National Bank163,600$4.53M0.00%+1,800+1.1%Added
Bank of America Corp168,775$4.67M0.00%−49,706−22.8%Reduced
Twinbeech Capital LP186,145$5.15M0.10%+186,145New
Jane Street Group, LLC201,996$5.59M0.01%+88,694+78.3%Added
Invesco Ltd.205,402$5.69M0.00%+134,536+189.8%Added
Driehaus Capital Management LLC218,153$6.04M0.08%−490−0.2%Reduced
Qube Research & Technologies Ltd218,432$6.05M0.02%+218,432New
Rafferty Asset Management, LLC226,942$6.28M0.04%−98,001−30.2%Reduced
Barclays PLC228,661$6.33M0.00%+42,336+22.7%Added
Susquehanna International Group, LLP242,472$6.71M0.01%+52,552+27.7%Added
Bessemer Group Inc243,442$6.74M0.01%−199,000−45.0%Reduced
Citadel Advisors LLC246,458$6.82M0.01%+246,458New
Millennium Management LLC247,816$6.86M0.01%−126,274−33.8%Reduced
Logos Global Management LP250,000$6.92M0.99%+250,000New
Alliancebernstein L.P.256,043$7.09M0.00%−72,595−22.1%Reduced
TD Asset Management Inc271,824$7.52M0.01%+140,012+106.2%Added
MPM Oncology Impact Management LP273,408$7.57M2.02%00.0%Unchanged
Nuveen Asset Management, LLC274,945$7.61M0.00%−2,445−0.9%Reduced
Victory Capital Management Inc342,359$9.48M0.01%+272,848+392.5%Added
Eventide Asset Management, LLC361,000$9.99M0.18%+365+0.1%Added
Bank of New York Mellon Corp420,366$11.6M0.00%+8,825+2.1%Added
Finepoint Capital LP427,000$11.8M5.89%+427,000New
Norges Bank439,687$12.2M0.00%+72,200+19.6%Added
DAFNA Capital Management LLC473,394$13.1M4.08%−38,891−7.6%Reduced
Integral Health Asset Management, LLC525,000$14.5M2.06%+169,000+47.5%Added
Candriam Luxembourg S.C.A.561,948$15.6M0.13%−18,000−3.1%Reduced
Goldman Sachs Group Inc627,445$17.4M0.00%−70,234−10.1%Reduced
Avidity Partners Management LP657,200$18.2M0.73%−417,800−38.9%Reduced
FMR LLC698,818$19.3M0.00%+116,106+19.9%Added
Rock Springs Capital Management LP725,152$20.1M0.54%+22,440+3.2%Added
D. E. Shaw & Co., Inc.745,271$20.6M0.03%+301,697+68.0%Added
Charles Schwab Investment Management Inc766,669$21.2M0.01%+55,558+7.8%Added
Morgan Stanley801,973$22.2M0.00%−181,522−18.5%Reduced
Northern Trust Corp933,125$25.8M0.01%+15,432+1.7%Added
Balyasny Asset Management LLC962,657$26.6M0.07%+962,657New
Frazier Life Sciences Management, L.P.997,455$27.6M1.84%+142,971+16.7%Added
Ameriprise Financial Inc1,211,856$33.5M0.01%−11,869−1.0%Reduced
The Column Group LLC1,230,641$34.1M22.62%−1,346,579−52.2%Reduced
Perceptive Advisors LLC1,321,795$36.6M1.23%+1,321,795New
Dimensional Fund Advisors LP1,661,863$46.0M0.02%−6,913−0.4%Reduced
Deerfield Management Company, L.P. (Series C)1,751,496$48.5M1.07%00.0%Unchanged
Casdin Capital, LLC1,810,000$50.1M5.59%00.0%Unchanged
Geode Capital Management, LLC2,072,732$57.4M0.01%+124,272+6.4%Added
Holocene Advisors, LP2,190,722$60.6M0.27%+12,662+0.6%Added
Janus Henderson Group PLC2,240,739$62.0M0.04%+922,897+70.0%Added
Artal Group S.A.2,529,737$70.0M3.05%+128,120+5.3%Added
Baker Bros. Advisors LP2,691,493$74.5M0.43%00.0%Unchanged
Woodline Partners LP3,145,445$87.1M1.02%−615,930−16.4%Reduced
Farallon Capital Management, L.L.C.3,325,480$92.0M0.52%+542,000+19.5%Added
State Street Corp3,867,610$107.1M0.01%−876,639−18.5%Reduced
BVF Inc3,981,212$110.2M2.97%−2,274,376−36.4%Reduced
JPMorgan Chase & Co4,279,919$118.5M0.01%+312,166+7.9%Added
Boxer Capital, LLC4,684,264$129.7M6.90%00.0%Unchanged
Bellevue Group AG4,721,500$130.7M2.11%−24,500−0.5%Reduced
Nextech Invest AG4,839,529$134.0M40.59%00.0%Unchanged
Price T Rowe Associates Inc5,094,706$141.0M0.02%+75,941+1.5%Added
EcoR1 Capital, LLC5,577,863$154.4M5.26%−1,620,837−22.5%Reduced
BlackRock Inc.8,871,414$245.6M0.01%+613,798+7.4%Added
Vanguard Group Inc9,643,591$266.9M0.01%+303,088+3.2%Added
Wellington Management Group LLP10,572,475$292.6M0.06%+282,786+2.7%Added
Sofinnova Investments, Inc.0$00.00%−520,377−100.0%Sold out
Polar Asset Management Partners Inc.0$00.00%−259,700−100.0%Sold out
Maven Securities LTD0$00.00%−100,000−100.0%Sold out
Trexquant Investment LP0$00.00%−52,181−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−23,162−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−18,762−100.0%Sold out
American Century Companies Inc0$00.00%−16,135−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−13,583−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−12,100−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−11,614−100.0%Sold out
Virginia Retirement Systems Et Al0$00.00%−10,900−100.0%Sold out
Simplex Trading, LLC0$00.00%−328−100.0%Sold out
Disciplined Investments, LLC0$00.00%−2−100.0%Sold out